EU Recommendations for 2026/2027 Flu Vaccine
The European Medicines Agency (EMA) has issued recommendations for the composition of seasonal flu vaccines for the 2026/2027 season. These recommendations are crucial for vaccine manufacturers to develop effective vaccines against anticipated influenza strains. The EMA's scientific committee assesses global epidemiological data to predict circulating viruses, ensuring that EU citizens receive the most protective vaccines available. This ongoing effort is vital for public health and disease prevention.
EU's EMA issues key recommendations for the 2026/2027 flu vaccine, protecting public health.